Cheryl A. Madsen
Conseiller Juridique Général chez VIRACTA THERAPEUTICS, INC.
Postes actifs de Cheryl A. Madsen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Conseiller Juridique Général | - | - |
Historique de carrière de Cheryl A. Madsen
Anciens postes connus de Cheryl A. Madsen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PELOTON THERAPEUTICS, INC. | Conseiller Juridique Général | - | - |
| Medivation, Inc. /Old/ | Corporate Officer/Principal | - | - |
| CALITHERA BIOSCIENCES, INC. | Conseiller Juridique Général | - | - |
Formation de Cheryl A. Madsen
| University of California, Santa Cruz | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| General Counsel | 3 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
- Bourse
- Insiders
- Cheryl A. Madsen
- Expérience
